远程监测用于心力衰竭:一项荟萃分析
该荟萃分析纳入1996年1月至2022年7月发表的随机试验和观察性研究,比较家庭远程监测系统(hTMS)与标准护理对心衰患者临床结局的影响。结果显示hTMS显著降低全因死亡、首次心衰住院和总心衰住院风险。
要点
- hTMS显著降低全因死亡风险(OR 0.84,95%CI 0.77-0.93)。
- hTMS显著降低首次心衰住院风险(OR 0.81,95%CI 0.74-0.88)。
- hTMS显著降低总心衰住院风险(发生率比0.85,95%CI 0.76-0.96)。
核心结论
- hTMS可降低心衰患者全因死亡和心衰相关住院风险,支持其临床应用。
- hTMS方法多样,未来研究需致力于标准化有效的hTMS模式。
研究设计与样本
- 系统检索四个文献数据库,纳入1996年1月至2022年7月发表的随机试验和观察性研究。
主要发现
- 与标准护理相比,hTMS使全因死亡风险显著降低16%(汇总OR 0.84,95%CI 0.77-0.93,I2=24%)。
- hTMS使首次心衰住院风险显著降低19%(OR 0.81,95%CI 0.74-0.88,I2=22%)。
- hTMS使总心衰住院风险降低15%(汇总发生率比0.85,95%CI 0.76-0.96,I2=70%)。
临床怎么用
- 可考虑对心衰患者使用hTMS以降低全因死亡和心衰住院风险。
- 应用时需注意hTMS方法尚未标准化,应选择经过验证的有效模式。
局限性
- hTMS的方法存在多样性,可能影响结果的适用性和标准化。
- 总心衰住院分析的异质性较高(I2=70%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Telemonitoring modalities in heart failure (HF) have been proposed as being essential for future organization and transition of HF care, however, efficacy has not been proven. A comprehensive meta-analysis of studies on home telemonitoring systems (hTMS) in HF and the effect on clinical outcomes are provided. METHODS AND RESULTS: A systematic literature search was performed in four bibliographic databases, including randomized trials and observational studies that were published during January 1996-July 2022. A random-effects meta-analysis was carried out comparing hTMS with standard of care. All-cause mortality, first HF hospitalization, and total HF hospitalizations were evaluated as study endpoints. Sixty-five non-invasive hTMS studies and 27 invasive hTMS studies enrolled 36 549 HF patients, with a mean follow-up of 11.5 months. In patients using hTMS compared with standard of care, a significant 16% reduction in all-cause mortality was observed [pooled odds ratio (OR): 0.84, 95% confidence interval (CI): 0.77-0.93, I2: 24%], as well as a significant 19% reduction in first HF hospitalization (OR: 0.81, 95% CI 0.74-0.88, I2: 22%) and a 15% reduction in total HF hospitalizations (pooled incidence rate ratio: 0.85, 95% CI 0.76-0.96, I2: 70%). CONCLUSION: These results are an advocacy for the use of hTMS in HF patients to reduce all-cause mortality and HF-related hospitalizations. Still, the methods of hTMS remain diverse, so future research should strive to standardize modes of effective hTMS.
引用
- Scholte, Gürgöze, Aydin, et al. Telemonitoring for heart failure: a meta-analysis. Eur Heart J. 2023. PMID: 37216272. doi:10.1093/eurheartj/ehad280
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。